References
- WeitzJKochMDebusJColorectal cancerLancet200536515316515639298
- DipiroRLTalbertRLYeeGCPharmacotherapy: A pathological ApproachNew YorkMcGraw-Hill2005
- MunkholmPThe incidence and prevalence of colorectal cancer in inflammatory bowlAlimentary Pharmacol Ther200318Suppl 215
- CalvertPMFruchtHThe genetics of colorectal cancerAnn Intern Med200313760361212353948
- SmalleyWRayWADaughertyJGriffinMRUse of nonsteroidal anti-inflammatory drugs and incidences of colorectal cancerArch Intern Med19991591611669927099
- ThunMJHenleyJPatronoCNonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issuesJ Nat Cancer Inst20029425226611854387
- FinckhAAronsonMDCardiovascular risks of cyclooxygenase-2 inhibitors: where we stand nowAnn Internal Med2005142212214
- NelsonNLCelecoxib shown effective in preventing colon polypJ Natl Cancer Inst20069866566716705118
- ArberNCyclooxygenase-2 inhibitors in colorectal cancer prevention: pointCancer Epidemiol Biomarkers Prev2008171852185718708371
- PietroiustiAGiulianoMVitaPFeacal pH and cancer of large bowelGastroenterology1983841273
- ThorntonJRHigh colonic pH promotes colorectal cancerLancet1981317108110836112450
- SamelsonSLNelsonRLNyhusLMProtective role of faecal pH in experimental colon carcinogenesisJ Royal Soc Med198578230233
- JainDPandaAKMajumdarDKEudragit S100 entrapped insulin microspheres for oral deliveryAAPS Pharm Sci Tech20056E100E107
- HoriMOnishiHMachidaYEvaluation of Eudragit-coated chitosan microparticles as an oral immune delivery systemInt J Pharm200529722323415885938
- JainDPandaAKMajumdarDKInsulin loaded Eudragit L100 microspheres for oral delivery: preliminary in vitro studiesJ Biomater Appl20062119521116443624
- CalisSAricaBKasHSHincalAA5-Fluorouracil-loaded alginate microspheres in chitosan gel for local therapy of breast cancerChitosan in Pharmacy and ChemistryMuzzarelliRAAMuzzarelliCGrottammare, ItalyAtec20026569
- RahmanZKohliKKharRKCharacerization of 5-fluorouracil microspheres for colonic deliveryAAPS Pharm Sci Tech20067E1E9
- ThakralNKRayARMajumdarDKEudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancerJ Mater Sci:Mater Med2010212691269920535630
- LehrCMBowstraJATukkerJJJungingerHEIntestinal transit of bioadhesive microspheres in an in situ loop in the ratJ Controlled Release1990135162
- NielsenCUAmstrupJSteffansenBEpidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell lineAm J Physiol Gastrointestinal Liver Physiol2001281G191G199
- LarsenMLarsenBBFrolundBNielsenCUTransport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cellsEur J Pharm Sci200835869518621125
- AnderbergEKArturssonPEpithelial transport of drugs in cell culture. VIII Effects of the pharmaceutical surfactant excipient sodium dodecyl sulfate on cell membrane and tight junctional permeability in human intestinal epithelial (Caco-2) cellsJ Pharm Sci1993823923988468683
- FreshneyRICulture of Animal Cells: A Manual of Basic TechniqueNew YorkWiley-Liss1987245256
- FronzaMBrumLWrasseMDevelopment and validation of a RP-HPLC method for the quantitation and dissolution studies of valdecoxibActa Farm Bonaerense200625117122
- WagnerJGInterpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsulesJ Pharm Sci196958125312575349114
- HiguchiTMechanism of sustained action medicationJ Pharm Sci1963521145114914088963
- HixsonAWCrowellJHDependence of reaction velocity upon surface and agitation. I Theoretical considerationsInd Eng Chem193123923931
- BourneDWPharmacokineticsModern PharmaceuticsBankerGSRhodesCTNew YorkMarcel Dekker20026792
- PeppasNAAnalysis of fickian and non-fickian drug release from polymersPharm Acta Helv1985601101114011621
- ChuehHRZiaHRhodesCPOptimization of sotalol floating and bioadhesive extended release tablet formulationsDrug Dev Ind Pharm19952117251747
- PeppasNABurimPASurface, interfacial and molecular aspects of polymer bioadhesion on soft tissuesJ Controlled Release19852257275
- WuSPolymer Interface and AdhesionNew YorkMarcel Dekker1982
- SmartJDKellawayIWWorthingtonHECAn in-vitro investigation of mucosa-adhesive materials for use in controlled drug deliveryJ Pharm Pharmacol1984362952996145763
- SmartJDDrug delivery using buccal adhesive systemAdv Drug Delivery Rev199311253270
- LeeJWParkJHRobinsonJRBioadhesive-based dosage forms: the next generationJ Pharm Sci20008985086610861586
- FilipeMICookeKBChanges in composition of mucin in the mucosa adjacent to carcinoma of the colon as compared with the normal: a biochemical investigationJ Clin Path1974273153184850957
- SmithMLHawcroftGHullMAThe effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of actionEur J Cancer20003666467410738133
- ShaharLLudmilaSDianaKCelecoxib and curcumin synergistically inhibit the growth of colorectal cancer cellsClin Cancer Res2005116738674416166455
- SchiffmannSMaierTJWobstIThe anti-proliferative potency of celecoxib is not a class effect of coxibsBiochem Pharmacol20087617918718547544